Differential Secretion of Atrial and Brain Natriuretic Peptide in Critically Ill Patients
- 1 September 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 93 (3) , 676-682
- https://doi.org/10.1097/00000539-200109000-00029
Abstract
Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormones with natriuretic, vasorelaxant, and aldosterone-inhibiting properties. We analyzed the plasma of 178 critically ill patients for ANP, BNP, aldosterone, and serum sodium concentration, as well as serum and urine osmolality and sodium filtration fraction. Mean plasma concentrations of ANP and BNP were increased in critically ill patients compared with healthy controls (ANP, 14.3 ± 5.8 pmol/L versus 8.8 ± 3.2 pmol/L, P PKeywords
This publication has 23 references indexed in Scilit:
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Natriuretic peptide system in human heart failure.Circulation, 1993
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionPublished by Elsevier ,1993
- Human C-type natriuretic peptide. Characterization of the gene and peptide.Hypertension, 1992
- Human brain natriuretic peptide-like immunoreactivity in human brainPeptides, 1992
- Brain natriuretic peptides: Differential localization of a new family of neuropeptidesNeuroscience Letters, 1989
- A new natriuretic peptide in porcine brainNature, 1988
- Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorptionNature, 1987
- Inhibition of Vasopressin Action by Atrial Natriuretic FactorScience, 1986
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981